BOOK
Dermatologic Manifestations of the Lower Extremity, An Issue of Clinics in Podiatric Medicine and Surgery, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Clinics in Podiatric Medicine and Surgery will focus on the dermatologic manifestations of the lower extremity. Articles will include: Fungal, Nail Surgery, Psoriasis, Eczema, Drug Reactions, Melanoma, and many more.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Dermatological Manifestations of the Lower Extremity\r | i | ||
| Copyright\r | ii | ||
| Clinics in Podiatric Medicine and Surgery | iii | ||
| Consulting Editor | iii | ||
| Editorial Board Members - USA | iii | ||
| Editorial Board Members - International | iii | ||
| Contributors | v | ||
| CONSULTING EDITOR | v | ||
| EDITOR | v | ||
| AUTHORS | v | ||
| Contents | vii | ||
| Foreword: Lower Extremity Skin Manifestations\r | vii | ||
| Preface: Lower Extremity Skin Manifestations: A Multidisciplinary Effort\r | vii | ||
| Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes\r | vii | ||
| Dermatologic Manifestations of the Lower Extremity: Nail Surgery\r | vii | ||
| The Human Papillomavirus and Its Role in Plantar Warts: A Comprehensive Review of Diagnosis and Management\r | vii | ||
| Psoriasis: Pathogenesis, Assessment, and Therapeutic Update\r | viii | ||
| Dermatologic Concerns of the Lower Extremity in the Pediatric Patient\r | viii | ||
| Importance of Vehicles in Topical Treatment of Fungal Infections\r | viii | ||
| Adverse Drug Reactions of the Lower Extremities\r | viii | ||
| Melanoma of the Foot\r | ix | ||
| Cutaneous Markers of Systemic Disease in the Lower Extremity\r | ix | ||
| Plantar Hyperhidrosis: An Overview\r | ix | ||
| CLINICS IN PODIATRIC\rMEDICINE AND SURGERY\r | x | ||
| FORTHCOMING ISSUES | x | ||
| October 2016 | x | ||
| January 2017 | x | ||
| April 2017 | x | ||
| July 2017 | x | ||
| October 2017 | x | ||
| RECENT ISSUES | x | ||
| April 2016 | x | ||
| January 2016 | x | ||
| October 2015 | x | ||
| July 2015 | x | ||
| Forword: Lower Extremity Skin Manifestations\r | xi | ||
| Preface: Lower Extremity Skin Manifestations: A Multidisciplinary Effort\r | xiii | ||
| Onychomycosis | 305 | ||
| Key points | 305 | ||
| INTRODUCTION | 305 | ||
| PATIENT EVALUATION | 306 | ||
| PHARMACOLOGIC TREATMENT OPTIONS: FOCUS ON TOPICAL THERAPY | 307 | ||
| NONPHARMACOLOGIC TREATMENTS | 310 | ||
| COMBINATION THERAPY | 310 | ||
| SURGICAL TREATMENT OPTIONS | 311 | ||
| MANAGEMENT OF RECURRENCE | 311 | ||
| EVALUATING PATIENT OUTCOMES AND LONG-TERM MANAGEMENT | 313 | ||
| SUMMARY | 314 | ||
| REFERENCES | 314 | ||
| Dermatologic Manifestations of the Lower Extremity | 319 | ||
| Key points | 319 | ||
| INTRODUCTION: PATIENT EVALUATION OVERVIEW | 319 | ||
| PATHOLOGIC CONDITIONS REQUIRING NAIL SURGERY (BENIGN AND MALIGNANT TUMORS, INFLAMMATORY DERMATOSES, CONGENITAL DISORDERS) | 320 | ||
| SURGICAL APPROACH AND TECHNIQUES | 323 | ||
| Scrub | 323 | ||
| Anesthesia | 325 | ||
| Bloodless Field | 325 | ||
| Punch | 326 | ||
| Shave | 329 | ||
| Biopsy of Longitudinal Erythronychia | 330 | ||
| Lateral Longitudinal Excision | 331 | ||
| En Bloc | 331 | ||
| COMPLICATIONS | 333 | ||
| SUMMARY | 333 | ||
| REFERENCES | 333 | ||
| The Human Papillomavirus and Its Role in Plantar Warts | 337 | ||
| Key points | 337 | ||
| INTRODUCTION | 337 | ||
| Human Papilloma Virus in Depth | 338 | ||
| Human Papilloma Virus Structure | 339 | ||
| PATIENT EVALUATION OVERVIEW | 340 | ||
| Clinical Manifestations of Human Papilloma Virus Infection | 340 | ||
| Evaluation of Patients with Plantar Warts | 344 | ||
| CLINICAL MANAGEMENT OF VERRUCA PEDIS | 345 | ||
| Pharmacologic and Nonpharmacologic Treatment Options | 345 | ||
| Folk remedies | 345 | ||
| Salicylic acid | 346 | ||
| Cryotherapy | 346 | ||
| Topical retinoids | 346 | ||
| Topical 5-fluorouracil | 346 | ||
| Cimetidine | 347 | ||
| Duct tape | 347 | ||
| Cantharidin | 347 | ||
| Bleomycin | 347 | ||
| Candida immunotherapy | 348 | ||
| Phytotherapy | 348 | ||
| Human papilloma virus vaccine | 349 | ||
| LASER | 349 | ||
| SURGICAL TREATMENT OPTIONS | 350 | ||
| SUMMARY/DISCUSSION | 350 | ||
| REFERENCES | 350 | ||
| Psoriasis | 355 | ||
| Key points | 355 | ||
| PATHOGENESIS | 356 | ||
| GENETICS | 356 | ||
| CLINICAL PRESENTATIONS OF PSORIASIS | 356 | ||
| NONDERMATOLOGIC MANIFESTATIONS | 357 | ||
| ARTHRITIS | 359 | ||
| COMORBIDITIES | 361 | ||
| TREATMENT | 362 | ||
| Topical Therapies | 362 | ||
| Phototherapy | 363 | ||
| Oral systemic therapies | 363 | ||
| Biologics | 363 | ||
| Adalimumab | 363 | ||
| Etanercept | 364 | ||
| Infliximab | 364 | ||
| Ustekinumab | 364 | ||
| Secukinumab | 364 | ||
| REFERENCES | 365 | ||
| Dermatologic Concerns of the Lower Extremity in the Pediatric Patient | 367 | ||
| Key points | 367 | ||
| DIAGNOSING SKIN DISEASE IN THE PEDIATRIC POPULATION | 367 | ||
| Observe | 367 | ||
| Ask | 368 | ||
| A Note on Skin Biopsies and Other Cutaneous Procedures in the Pediatric Patient | 368 | ||
| ENVIRONMENTALLY INDUCED SKIN DISORDERS | 369 | ||
| Sun Exposure | 369 | ||
| Heat and Cold | 369 | ||
| Bites and Stings and Infestations | 370 | ||
| Trauma | 370 | ||
| GENODERMATOSES | 371 | ||
| Vörner-Unna-Thost Type | 371 | ||
| Vohwinkel Type | 371 | ||
| Pachyonychia Congenita | 371 | ||
| Tuberous Sclerosis | 371 | ||
| Treatment of Genodermatoses | 372 | ||
| BACTERIAL INFECTIONS | 372 | ||
| Impetigo | 372 | ||
| Cellulitis | 372 | ||
| Folliculitis | 372 | ||
| Pitted Keratolysis/Erythrasma | 373 | ||
| Pseudomonas Hot Foot Syndrome | 373 | ||
| VIRAL INFECTIONS | 373 | ||
| Viral Exanthems | 373 | ||
| Measles | 373 | ||
| Rubella | 373 | ||
| Fifth disease or erythema infectiosum | 373 | ||
| Varicella Zoster | 373 | ||
| Herpes simplex | 374 | ||
| Hand-foot-and-mouth disease | 374 | ||
| Molluscum Contagiosum | 374 | ||
| Verrucae | 374 | ||
| FUNGAL INFECTIONS | 375 | ||
| Tinea Capitis | 375 | ||
| Tinea Pedis | 375 | ||
| Tinea Incognito | 375 | ||
| Onychomycosis | 376 | ||
| Distal (or distal lateral) subungual | 376 | ||
| Proximal subungual | 376 | ||
| Candidal | 376 | ||
| Superficial white | 376 | ||
| Candidiasis | 376 | ||
| ECZEMA/DERMATITIS | 377 | ||
| Overview | 377 | ||
| Endogenous Eczema | 377 | ||
| Atopic dermatitis | 377 | ||
| Juvenile plantar dermatosis (sweaty sock dermatitis) | 377 | ||
| Pompholyx (dyshidrotic eczema) | 378 | ||
| Exogenous Eczema/Dermatitis | 378 | ||
| Allergic contact dermatitis | 378 | ||
| Irritant contact dermatitis | 378 | ||
| Focus on Eczema/Dermatitis of the Lower Extremity | 379 | ||
| General Management of Eczema | 379 | ||
| PSORIASIS | 379 | ||
| Plaque Psoriasis | 379 | ||
| Pustular Psoriasis | 380 | ||
| Guttate Psoriasis | 380 | ||
| Focus on Psoriasis of the Lower Extremity | 380 | ||
| General Management of Psoriasis | 380 | ||
| NEVI | 381 | ||
| NAILS | 382 | ||
| REFERENCES | 382 | ||
| Importance of Vehicles in Topical Treatment of Fungal Infections | 385 | ||
| Key points | 385 | ||
| TOPICAL DRUG DELIVERY BASICS | 386 | ||
| Secondary Formulations | 388 | ||
| THE DOSAGE FORM | 388 | ||
| TREATMENT SELECTION | 390 | ||
| Anticipated Efficacy | 390 | ||
| Supportive Effects | 391 | ||
| Practical Considerations | 391 | ||
| SUMMARY | 392 | ||
| REFERENCES | 393 | ||
| Adverse Drug Reactions of the Lower Extremities | 397 | ||
| Key points | 397 | ||
| ADVERSE DRUG REACTIONS TO TOPICAL MEDICATIONS | 398 | ||
| ADVERSE DRUG REACTIONS TO SYSTEMIC AGENTS | 399 | ||
| FIXED DRUG ERUPTIONS | 399 | ||
| MEDICATION-INDUCED LOWER LEG EDEMA | 400 | ||
| ERYTHEMA NODOSUM CAUSED BY MEDICATIONS | 400 | ||
| MEDICATION-INDUCED PIGMENTATION OF THE SKIN | 400 | ||
| MEDICATION-INDUCED PIGMENTATION OF THE NAILS | 402 | ||
| SKIN NECROSIS CAUSED BY ANTICOAGULANTS | 402 | ||
| ADVERSE DRUG REACTIONS TO CHEMOTHERAPEUTIC AGENTS | 403 | ||
| CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA | 403 | ||
| CHEMOTHERAPY-INDUCED DERMATOLOGIC CHANGES INVOLVING THE LOWER EXTREMITY CAUSED BY VARIOUS CHEMOTHERAPY AGENTS | 403 | ||
| CHEMOTHERAPY-INDUCED NAIL CHANGES | 404 | ||
| ADVERSE REACTIONS TO IMMUNOSUPPRESSIVE OR IMMUNOMODULATORY AGENTS | 405 | ||
| OTHER NAIL CHANGES CAUSED BY MEDICATIONS | 405 | ||
| REFERENCES | 406 | ||
| Melanoma of the Foot | 409 | ||
| Key points | 409 | ||
| INTRODUCTION | 409 | ||
| TYPES OF MELANOMA | 409 | ||
| AMELANOTIC MELANOMA | 410 | ||
| NAIL MELANOMA | 410 | ||
| HOW COMMON IS MELANOMA ON THE FOOT? | 411 | ||
| CAUSE | 412 | ||
| CLINICAL PRESENTATION OF MELANOMA ON THE FOOT | 413 | ||
| PRESENTATION OF MELANOMA OF THE NAIL UNIT | 414 | ||
| DERMOSCOPY | 417 | ||
| DIAGNOSIS AND STAGING OF MELANOMA | 417 | ||
| PROGNOSIS | 418 | ||
| CURRENT AND RECENT ADVANCES IN THE TREATMENT OF MELANOMA | 419 | ||
| REFERENCES | 420 | ||
| Cutaneous Markers of Systemic Disease in the Lower Extremity | 423 | ||
| Key points | 423 | ||
| INTRODUCTION | 423 | ||
| DIABETES MELLITUS | 423 | ||
| Diabetic Dermopathy | 423 | ||
| Bullosis Diabeticorum | 424 | ||
| Diabetic Eruptive Xanthomas | 425 | ||
| Necrobiosis Lipoidica Diabeticorum | 425 | ||
| RENAL DISEASE | 426 | ||
| Acquired Perforating Dermatosis of End-stage Renal Disease (Kyrle Disease) | 426 | ||
| Nephrogenic Fibrosing Dermopathy | 426 | ||
| Calciphylaxis | 427 | ||
| CARDIOVASCULAR DISORDERS | 428 | ||
| Raynaud Phenomenon | 428 | ||
| Subacute Bacterial Endocarditis | 428 | ||
| Henoch-Schönlein Purpura | 428 | ||
| THYROID CONDITIONS | 429 | ||
| Thyroid Dermopathy (Pretibial Myxedema) | 429 | ||
| MALIGNANCY | 429 | ||
| Bazex Syndrome | 430 | ||
| Glucagonoma Syndrome | 430 | ||
| Malignant Acanthosis Nigricans | 430 | ||
| Ichthyosis | 430 | ||
| Palmoplantar Keratoderma | 430 | ||
| Trousseau Syndrome | 431 | ||
| Werner Syndrome | 431 | ||
| GENETIC DISORDERS | 431 | ||
| Neurofibromatosis | 431 | ||
| Tuberous Sclerosis | 431 | ||
| THE ERYTHEMAS | 432 | ||
| Erythema Multiforme | 432 | ||
| Erythema Nodosum | 432 | ||
| Erythema Annulare Centrifugum | 433 | ||
| Palmoplantar Erythema | 434 | ||
| MISCELLANEOUS DISORDERS | 434 | ||
| Keratoderma Blennorrhagicum | 434 | ||
| Pyoderma Gangrenosum | 435 | ||
| Vitiligo | 436 | ||
| NAIL MANIFESTATIONS OF INTERNAL DISEASE | 437 | ||
| Beau Lines | 437 | ||
| Yellow Nail Syndrome | 437 | ||
| Koilonychia | 437 | ||
| Digital Clubbing | 437 | ||
| Terry Nails | 438 | ||
| SUMMARY | 439 | ||
| REFERENCES | 439 | ||
| Plantar Hyperhidrosis | 441 | ||
| Key points | 441 | ||
| INTRODUCTION | 441 | ||
| PATIENT EVALUATION OVERVIEW | 442 | ||
| PHARMACOLOGIC TREATMENT OPTIONS | 445 | ||
| NONPHARMACOLOGIC TREATMENT OPTIONS | 448 | ||
| SUMMARY/DISCUSSION | 449 | ||
| ACKNOWLEDGMENT | 449 | ||
| REFERENCES | 450 | ||
| Index | 453 |